A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Clinical trial NCT06623396 · RECRUITING

Trial details

NCT number: NCT06623396
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelin Positive Mesothelin-Expressing Tumors Esophageal Adenocarcinoma Esophageal Adenocarcinomas Esophagogastric Adenocarcinoma Peritoneal Carcinomatosis Breast Neoplasms Diabetes Mellitus

Start date: 2024-09-30
Primary completion: 2028-09-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.